Matches in SemOpenAlex for { <https://semopenalex.org/work/W4293338131> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W4293338131 endingPage "84" @default.
- W4293338131 startingPage "84" @default.
- W4293338131 abstract "Background: Ovarian cancer is one of the most common malignancies in female patients. In recent years, immunohistochemistry (IHC) has emerged as an important tool in the diagnosis of ovarian tumors. The study aimed to assess estrogen receptors (ERs), progesterone receptors (PRs), Her-2-neu, and Ki-67 by IHC in surface epithelial ovarian tumors and to correlate the findings with different variables. Materials and Methods: It was a cross-sectional study. Oophorectomy/salpingo-oophorectomy/cystectomy specimens were included in this study. IHC was done on 10% neutral buffer formalin-fixed paraffin-embedded tissue sections by using Dako FLEX Ready to use mouse monoclonal antibodies and DakoEnvisionTM FLEX/HRP detection reagent. Results: The study includes 81 cases of surface epithelial ovarian tumors (a benign serous tumor [20], a benign mucinous tumor [18], a borderline mucinous tumor [5], low-grade serous carcinoma [8], high-grade serous carcinoma [19], mucinous carcinoma [7], endometrioid carcinoma [2], borderline Brenner tumor [1], and malignant Brenner tumor [1]. ER had higher expression in malignant cases (51.33%) than in benign cases (15.8%). PR had higher expression in malignant tumors (54.05%) incomparable to benign (18.42%) and borderline tumors (16.66%). PR had higher expression in high grade. Expression of Her-2-neu positivity was found to be 29.7% out of the total 81 cases. Her-2-neu was found in 11 high-grade tumors among 31 malignant cases. CA-125 levels were significantly higher in malignant ovarian tumors (P = 0.0143). Proliferation activity was considered low if proliferation index (PI) <10% and high if PI >10%. The study showed high PI in malignant tumors. Conclusion: Expression of these marks in adjunct to H&E diagnosis may prove beneficial in differentiating benign, borderline, and malignant cases, in which a diagnosis of borderline cases based on sole H & E is doubtful." @default.
- W4293338131 created "2022-08-27" @default.
- W4293338131 creator A5000190486 @default.
- W4293338131 creator A5031208551 @default.
- W4293338131 creator A5083157618 @default.
- W4293338131 date "2022-01-01" @default.
- W4293338131 modified "2023-09-26" @default.
- W4293338131 title "A cross-sectional study of immunohistochemical evaluation of surface epithelial ovarian tumors" @default.
- W4293338131 cites W1539293978 @default.
- W4293338131 cites W1887353051 @default.
- W4293338131 cites W1966024712 @default.
- W4293338131 cites W2008389188 @default.
- W4293338131 cites W2057964929 @default.
- W4293338131 cites W2064657094 @default.
- W4293338131 cites W2074596528 @default.
- W4293338131 cites W2076083481 @default.
- W4293338131 cites W2086757750 @default.
- W4293338131 cites W2087678109 @default.
- W4293338131 cites W2100762242 @default.
- W4293338131 cites W2131295892 @default.
- W4293338131 cites W2170939663 @default.
- W4293338131 cites W2733135516 @default.
- W4293338131 cites W4242375323 @default.
- W4293338131 doi "https://doi.org/10.4103/mgmj.mgmj_75_21" @default.
- W4293338131 hasPublicationYear "2022" @default.
- W4293338131 type Work @default.
- W4293338131 citedByCount "0" @default.
- W4293338131 crossrefType "journal-article" @default.
- W4293338131 hasAuthorship W4293338131A5000190486 @default.
- W4293338131 hasAuthorship W4293338131A5031208551 @default.
- W4293338131 hasAuthorship W4293338131A5083157618 @default.
- W4293338131 hasBestOaLocation W42933381311 @default.
- W4293338131 hasConcept C121608353 @default.
- W4293338131 hasConcept C126322002 @default.
- W4293338131 hasConcept C142724271 @default.
- W4293338131 hasConcept C143998085 @default.
- W4293338131 hasConcept C150173356 @default.
- W4293338131 hasConcept C204232928 @default.
- W4293338131 hasConcept C2777632260 @default.
- W4293338131 hasConcept C2777751288 @default.
- W4293338131 hasConcept C2780084626 @default.
- W4293338131 hasConcept C2780427987 @default.
- W4293338131 hasConcept C530470458 @default.
- W4293338131 hasConcept C71924100 @default.
- W4293338131 hasConcept C84606932 @default.
- W4293338131 hasConcept C98717036 @default.
- W4293338131 hasConceptScore W4293338131C121608353 @default.
- W4293338131 hasConceptScore W4293338131C126322002 @default.
- W4293338131 hasConceptScore W4293338131C142724271 @default.
- W4293338131 hasConceptScore W4293338131C143998085 @default.
- W4293338131 hasConceptScore W4293338131C150173356 @default.
- W4293338131 hasConceptScore W4293338131C204232928 @default.
- W4293338131 hasConceptScore W4293338131C2777632260 @default.
- W4293338131 hasConceptScore W4293338131C2777751288 @default.
- W4293338131 hasConceptScore W4293338131C2780084626 @default.
- W4293338131 hasConceptScore W4293338131C2780427987 @default.
- W4293338131 hasConceptScore W4293338131C530470458 @default.
- W4293338131 hasConceptScore W4293338131C71924100 @default.
- W4293338131 hasConceptScore W4293338131C84606932 @default.
- W4293338131 hasConceptScore W4293338131C98717036 @default.
- W4293338131 hasIssue "1" @default.
- W4293338131 hasLocation W42933381311 @default.
- W4293338131 hasOpenAccess W4293338131 @default.
- W4293338131 hasPrimaryLocation W42933381311 @default.
- W4293338131 hasRelatedWork W1981489196 @default.
- W4293338131 hasRelatedWork W2010224550 @default.
- W4293338131 hasRelatedWork W2100038149 @default.
- W4293338131 hasRelatedWork W2519250555 @default.
- W4293338131 hasRelatedWork W2559344923 @default.
- W4293338131 hasRelatedWork W2770618116 @default.
- W4293338131 hasRelatedWork W2805900528 @default.
- W4293338131 hasRelatedWork W2910889539 @default.
- W4293338131 hasRelatedWork W3210326642 @default.
- W4293338131 hasRelatedWork W4231785194 @default.
- W4293338131 hasVolume "9" @default.
- W4293338131 isParatext "false" @default.
- W4293338131 isRetracted "false" @default.
- W4293338131 workType "article" @default.